Which type of RNA is NOT directly involved in the process of translation?
Which phase of cell division is most appropriate for chromosomal studies?
Which of the following is NOT a location where circular DNA is found in eukaryotic cells?
Ectrodactyly is an autosomal dominant trait that causes missing middle fingers (lobster claw malformation). A grandfather and grandson both have ectrodactyly, but the intervening father has normal hands by x-ray. Which of the following terms best applies to this family?
Which amino acid is coded for by the initiator codon?
Which of the following is NOT a substrate for aminoacyl-tRNA synthetase?
Fidelity of protein translation depends on which of the following?
Which of the following is NOT true regarding DNA replication?
Which enzyme involved in translation is often referred to as the 'Fidelity enzyme'?
Pseudouridine is primarily found in which type of RNA molecule?
Explanation: **Explanation:** The correct answer is **Small nuclear RNA (snRNA)** because its primary function is localized within the nucleus, specifically in **splicing**, rather than the cytoplasmic process of translation. 1. **Why snRNA is the correct answer:** snRNAs complex with specific proteins to form **snRNPs** (Small Nuclear Ribonucleoprotein particles), which are the core components of the **spliceosome**. Their role is to identify and remove introns from pre-mRNA and ligate exons together. Since translation occurs in the cytoplasm after mRNA processing is complete, snRNA is not directly involved in protein synthesis. 2. **Why the other options are incorrect:** * **mRNA (Messenger RNA):** Acts as the template for translation. It carries the genetic code from DNA to the ribosome. * **tRNA (Transfer RNA):** Acts as the "adapter" molecule. It carries specific amino acids to the ribosome and matches them to the mRNA codons via its anticodon loop. * **rRNA (Ribosomal RNA):** The structural and catalytic component of ribosomes. It ensures proper alignment of mRNA and catalyzes peptide bond formation (peptidyl transferase activity). **High-Yield NEET-PG Pearls:** * **Splicing Pathology:** Antibodies against snRNPs (specifically **Anti-Smith antibodies**) are highly specific for **Systemic Lupus Erythematosus (SLE)**. * **Ribozyme:** rRNA is a classic example of a ribozyme (an RNA with enzymatic activity). * **RNA Polymerases:** Remember the "RMT" mnemonic for eukaryotes: Pol I → **r**RNA, Pol II → **m**RNA (and snRNA), Pol III → **t**RNA.
Explanation: **Explanation:** **Metaphase** is the most appropriate phase for chromosomal studies (Karyotyping) because chromosomes reach their **maximum state of condensation** during this stage. At metaphase, the sister chromatids are clearly visible, aligned at the equatorial plate, and possess distinct morphologies (size, shape, and centromere position). This makes them easiest to visualize under a light microscope after staining (e.g., Giemsa staining). **Analysis of Incorrect Options:** * **Prophase (A):** Chromatin begins to condense, but the chromosomes are still elongated, entangled, and not yet distinct enough for detailed structural analysis. * **Anaphase (D):** Sister chromatids begin to pull apart toward opposite poles. Because they are moving and no longer paired, it is difficult to assess their full morphology or count them accurately. * **Telophase (C):** Chromosomes begin to de-condense back into chromatin to form the daughter nuclei, making them invisible as distinct structures. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Colchicine/Colcemid:** In cytogenetic laboratories, cell division is intentionally arrested in metaphase using **Colchicine**, which inhibits spindle fiber formation by binding to tubulin. * **Karyotyping Indications:** Used to detect numerical aberrations (e.g., Trisomy 21) or structural aberrations (e.g., Translocations like t(9;22) in CML). * **Best Sample:** Peripheral blood lymphocytes are most commonly used for postnatal karyotyping; they are stimulated to divide using **Phytohemagglutinin (PHA)**.
Explanation: **Explanation:** In eukaryotic cells, the organization of genetic material differs significantly based on the organelle. The **Nucleus** (Option A) contains **linear DNA** organized into complex structures called chromosomes, wrapped around histone proteins. This linear arrangement is a hallmark of eukaryotic nuclear genomes, distinguishing them from the circular genomes of prokaryotes. **Analysis of Options:** * **Mitochondrion (Option C):** According to the endosymbiotic theory, mitochondria originated from ancient bacteria. Consequently, they possess their own **double-stranded circular DNA (mtDNA)**, which is inherited maternally and lacks histones. * **Yeast (Option D):** While yeast is a eukaryote, it is unique because many strains contain the **2-micron circle**, a specialized extrachromosomal circular DNA element. * **Plasmid (Option B):** Plasmids are small, circular, extrachromosomal DNA molecules. While primarily associated with bacteria, they are found in certain lower eukaryotes like yeast and fungi. **High-Yield Clinical Pearls for NEET-PG:** * **Mitochondrial DNA (mtDNA):** It is circular, 16.6 kb in size, and encodes 13 polypeptides of the respiratory chain, 22 tRNAs, and 2 rRNAs. Mutations here lead to "Maternal Inheritance" patterns (e.g., LHON, MELAS). * **Exceptions:** While nuclear DNA is linear, some specialized processes (like the formation of extrachromosomal circular DNA or eccDNA) can occur in cancer cells, but the standard physiological form remains linear. * **Prokaryotes:** Almost always possess a single, circular chromosome located in the nucleoid.
Explanation: ### Explanation **1. Why Incomplete Penetrance is Correct:** Penetrance refers to the percentage of individuals with a specific genotype who actually manifest the corresponding phenotype. **Incomplete (reduced) penetrance** occurs when an individual carries a disease-causing allele but does not show any clinical signs of the condition. In this scenario, the trait is **autosomal dominant**. Since the grandfather and grandson are affected, the intervening father *must* carry the mutant allele to pass it on. However, because his hands are clinically and radiologically normal, the gene has "skipped a generation" in terms of expression. This is a classic hallmark of incomplete penetrance. **2. Analysis of Incorrect Options:** * **B. New Mutation (De novo):** This would explain a child having a condition without a family history. It does not explain how a grandfather and grandson are both affected while the father is phenotypically normal. * **C. Variable Expressivity:** This refers to the *degree* or severity of the phenotype among individuals with the same genotype (e.g., one person has a mild claw, another has severe malformation). Since the father has "normal hands," he shows no expression at all, making penetrance the more accurate term. * **D. Germinal Mosaicism:** This occurs when a mutation is present in the germline (gonads) but not in the somatic cells. While it can lead to multiple affected offspring from an unaffected parent, it is less likely than incomplete penetrance for a well-known AD trait like ectrodactyly. **3. High-Yield Clinical Pearls for NEET-PG:** * **Calculation:** Penetrance = (Number of people with phenotype / Number of people with genotype) × 100. * **Common Examples:** Retinoblastoma (Rb gene), Otosclerosis, and BRCA1/BRCA2 mutations often show incomplete penetrance. * **Distinction:** Remember, **Penetrance** is an "all-or-none" phenomenon (Do you have it?), while **Expressivity** is a "shades of gray" phenomenon (How bad is it?).
Explanation: **Explanation:** In molecular biology, the translation of mRNA into a protein begins at a specific sequence known as the **initiator codon**, which is almost universally **AUG**. This codon specifies the amino acid **Methionine**. 1. **Why Methionine is Correct:** The genetic code is read in triplets (codons). The AUG codon serves a dual function: it acts as the "Start" signal for the ribosome to begin protein synthesis and simultaneously codes for Methionine. In eukaryotes, the initiator tRNA carries unmodified methionine, whereas in prokaryotes (and mitochondria), it carries **N-formylmethionine (fMet)**. 2. **Why Other Options are Incorrect:** * **Cystine (A):** This is a dimer of two Cysteine molecules. Cysteine is coded by UGU and UGC. * **Arginine (B):** A basic amino acid coded by six different codons (CGU, CGC, CGA, CGG, AGA, AGG), none of which function as start signals. * **Lysine (D):** A basic amino acid coded by AAA and AAG. **High-Yield Clinical Pearls for NEET-PG:** * **Kozak Consensus Sequence:** In eukaryotes, the efficiency of translation initiation is increased if the AUG is embedded within a specific sequence (ACCAUGG). * **Shine-Dalgarno Sequence:** In prokaryotes, this purine-rich sequence helps the 16S rRNA of the small ribosomal subunit align correctly with the AUG start codon. * **Non-Standard Start Codons:** Occasionally, GUG or UUG can act as initiator codons in prokaryotes, but they still recruit fMet-tRNA. * **Post-translational Modification:** The initial methionine is often enzymatically removed from the N-terminus of the mature protein.
Explanation: ### Explanation **Aminoacyl-tRNA synthetases (aaRS)** are the enzymes responsible for the "charging" step of translation. They catalyze the attachment of a specific amino acid to its corresponding tRNA. This process requires three substrates: a **proteogenic amino acid**, **ATP**, and a **specific tRNA**. **Why Hydroxyproline is the Correct Answer:** Hydroxyproline is a **non-proteogenic amino acid**. It is not incorporated into proteins during initial translation because there is no genetic code (codon) or specific tRNA for it. Instead, hydroxyproline is formed via **post-translational modification**. In collagen synthesis, specific proline residues are hydroxylated by the enzyme *prolyl hydroxylase* only after the polypeptide chain has already been synthesized on the ribosome. Since it is not added during translation, it does not serve as a substrate for aminoacyl-tRNA synthetase. **Analysis of Incorrect Options:** * **A, B, and C (Lysine, Cysteine, Methionine):** These are all standard, proteogenic amino acids. Each has a specific aminoacyl-tRNA synthetase (e.g., Methionyl-tRNA synthetase) that recognizes the amino acid and its cognate tRNA to form an aminoacyl-tRNA complex for protein synthesis. **High-Yield NEET-PG Pearls:** * **Post-translational Modification:** Hydroxyproline and Hydroxylysine are hallmark features of **Collagen**. * **Cofactor Requirement:** Prolyl hydroxylase requires **Vitamin C (Ascorbic acid)**, Fe²⁺, and α-ketoglutarate. Deficiency leads to Scurvy due to defective collagen cross-linking. * **Accuracy:** Aminoacyl-tRNA synthetases have "proofreading" or editing sites to ensure high fidelity; this is often called the **"Second Genetic Code."** * **Energy:** The charging reaction consumes **two high-energy phosphate bonds** (ATP → AMP + PPi).
Explanation: **Explanation:** The **fidelity of protein translation** refers to the accuracy with which the genetic code is translated into a specific sequence of amino acids. This process relies on two critical recognition steps: matching the correct amino acid to its tRNA and matching the tRNA anticodon to the mRNA codon. **Why Aminoacyl-tRNA Synthetase is correct:** Aminoacyl-tRNA synthetases (aaRS) are the "true translators" of the genetic code. They catalyze the attachment of a specific amino acid to its corresponding tRNA (charging). * **Double-Sieve Mechanism:** These enzymes possess high specificity for both the amino acid and the tRNA. If an incorrect amino acid is attached, the enzyme’s **editing/proofreading site** hydrolyzes the bond before the tRNA is released. This ensures that the error rate remains extremely low (approx. 1 in 10,000), maintaining the integrity of the proteome. **Why other options are incorrect:** * **A & C. RNA Polymerase / mRNA Polymerase:** These enzymes are involved in **transcription** (DNA to RNA), not translation. While they have some proofreading ability, they do not influence the accuracy of protein synthesis at the ribosome. (Note: "mRNA polymerase" is a redundant term for RNA Polymerase II). * **B. DNA Polymerase:** This enzyme is responsible for **DNA replication**. While it has the highest fidelity (due to 3'→5' exonuclease activity), it operates in the nucleus and is unrelated to the translation process. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Aminoacyl-tRNA synthetase provides the **"Second Genetic Code."** * **Energy Requirement:** The charging of tRNA requires **ATP**, while the movement of the ribosome during translation requires **GTP**. * **Antibiotic Link:** Mupirocin (topical antibiotic) acts by inhibiting bacterial **Isoleucyl-tRNA synthetase**, thereby halting protein synthesis. * **Autoimmunity:** Antibodies against Histidyl-tRNA synthetase (**Anti-Jo-1**) are diagnostic markers for Polymyositis/Dermatomyositis.
Explanation: ### Explanation **1. Why Option A is the correct answer (The "NOT" true statement):** DNA replication occurs exclusively during the **S-phase (Synthetic phase)** of the Interphase, not the M-phase (Mitosis). The M-phase is dedicated to the physical separation of chromosomes and cell division. In the S-phase, the DNA content of the cell doubles (from 2n to 4n), ensuring that each daughter cell receives a complete genetic complement. **2. Analysis of incorrect options (True statements):** * **Option B (Sister chromatids are formed):** During the S-phase, each chromosome is replicated to produce two identical copies called sister chromatids, which remain attached at the centromere until Anaphase of mitosis. * **Option C (Follows base pairing rule):** DNA replication relies on **Chargaff’s rule** (Complementary Base Pairing). DNA polymerase adds nucleotides based on the template strand: Adenine pairs with Thymine (A=T) and Guanine pairs with Cytosine (G≡C). * **Option D (Semi-conservative process):** As proven by the **Meselson-Stahl experiment**, each new DNA double helix consists of one "old" parental strand and one "newly" synthesized daughter strand. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Directionality:** DNA synthesis always occurs in the **5' → 3' direction**. * **Enzymes:** **Helicase** unwinds the helix; **Topoisomerase (DNA Gyrase in prokaryotes)** relieves torsional strain; **DNA Polymerase III** is the primary replicative enzyme in prokaryotes. * **Inhibitors:** Fluoroquinolones (e.g., Ciprofloxacin) inhibit DNA Gyrase; Etoposide/Teniposide inhibit human Topoisomerase II, acting as anticancer agents. * **Rate-limiting step:** The initiation of DNA replication is the most regulated step of the cell cycle.
Explanation: **Explanation:** The correct answer is **Amino acyl-tRNA synthetase**. **Why it is the 'Fidelity Enzyme':** Translation requires extreme precision to ensure the correct amino acid is incorporated into the polypeptide chain. Amino acyl-tRNA synthetase is responsible for the "charging" of tRNA—a two-step process where it attaches a specific amino acid to its corresponding tRNA. It is called the **'Fidelity enzyme'** because it performs the **second genetic code** function. It possesses a unique **proofreading (editing) mechanism** that can hydrolyze the bond if an incorrect amino acid is attached. Since the ribosome cannot distinguish if a tRNA is carrying the right amino acid, the accuracy of protein synthesis depends entirely on this enzyme's ability to match the correct pair. **Analysis of Incorrect Options:** * **A. DNA polymerase:** While it has high fidelity and proofreading (3' to 5' exonuclease activity), it is involved in **DNA Replication**, not translation. * **B. RNA polymerase:** Involved in **Transcription**. It lacks robust proofreading mechanisms compared to DNA polymerase and is not involved in the translation process. * **D. Amino acyl-reductase:** This is a distractor; it is not a standard enzyme involved in the central dogma of molecular biology. **High-Yield Clinical Pearls for NEET-PG:** * **Energy Requirement:** The charging of tRNA by amino acyl-tRNA synthetase requires **ATP** (converted to AMP + PPi). * **Linkage:** The amino acid is attached to the **3' acceptor arm (CCA sequence)** of the tRNA via an ester bond. * **Mnemonic:** "Fidelity = Faithfulness." The enzyme ensures the "faith" between the codon and the amino acid is kept.
Explanation: **Explanation:** **1. Why tRNA is correct:** Pseudouridine ($\Psi$) is the most abundant post-transcriptionally modified nucleoside found in RNA. It is formed by the isomerization of uridine, where the ribose sugar is attached to the C5 position instead of the N1 position. While it exists in other RNAs, it is a **hallmark characteristic of tRNA**. Specifically, it is found in the **T$\Psi$C arm** (the "T-loop"), which is essential for the binding of tRNA to the ribosomal surface during protein synthesis. **2. Why other options are incorrect:** * **DNA:** DNA contains the standard bases (A, G, C, T) and does not typically contain pseudouridine. * **rRNA:** While rRNA does contain some pseudouridine modifications (important for ribosome structure), it is not the primary diagnostic location emphasized in medical biochemistry compared to the structural loops of tRNA. * **mRNA:** Eukaryotic mRNA undergoes modifications like the 5' cap and 3' poly-A tail, but pseudouridine is not a primary or defining feature of standard mRNA molecules. **3. High-Yield Clinical Pearls for NEET-PG:** * **The T$\Psi$C Arm:** Contains Ribothymidine, Pseudouridine, and Cytidine. It is responsible for tRNA recognition by the ribosome. * **The DHU Arm:** Contains Dihydrouridine and is responsible for recognition by the specific aminoacyl tRNA synthetase. * **The Anticodon Arm:** Recognizes the codon on mRNA. * **The CCA Tail:** All tRNAs end in a 3' CCA sequence (added post-transcriptionally), which is the attachment site for the amino acid. * **Clinical Marker:** Elevated levels of pseudouridine in the urine can be a biochemical marker for increased RNA turnover, often seen in certain **malignancies**.
DNA Replication and Repair Mechanisms
Practice Questions
Transcription Factors and Gene Regulation
Practice Questions
Epigenetics and DNA Methylation
Practice Questions
RNA Processing and Splicing
Practice Questions
miRNA and RNA Interference
Practice Questions
Protein Synthesis and Post-Translational Modifications
Practice Questions
Genomics and Human Genome Project
Practice Questions
Single Nucleotide Polymorphisms
Practice Questions
Gene Therapy Approaches
Practice Questions
CRISPR-Cas9 and Genome Editing
Practice Questions
DNA Fingerprinting and Forensics
Practice Questions
Molecular Basis of Genetic Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free